Concepedia

Publication | Open Access

Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern

DOIFull Paper Access

424

Citations

24

References

2022

Year

Laura Vangeel, Winston Chiu, Steven De Jonghe, Piet Maes, Bram Slechten, Joren Raymenants, Emmanuel André, Pieter Leyssen, Johan Neyts, Dirk Jochmans
Antiviral Research

References

YearCitations

Page 1